Correlation Between Centessa Pharmaceuticals and RAPT Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and RAPT Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and RAPT Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and RAPT Therapeutics, you can compare the effects of market volatilities on Centessa Pharmaceuticals and RAPT Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of RAPT Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and RAPT Therapeutics.

Diversification Opportunities for Centessa Pharmaceuticals and RAPT Therapeutics

-0.23
  Correlation Coefficient

Very good diversification

The 3 months correlation between Centessa and RAPT is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and RAPT Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RAPT Therapeutics and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with RAPT Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RAPT Therapeutics has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and RAPT Therapeutics go up and down completely randomly.

Pair Corralation between Centessa Pharmaceuticals and RAPT Therapeutics

Given the investment horizon of 90 days Centessa Pharmaceuticals PLC is expected to generate 0.76 times more return on investment than RAPT Therapeutics. However, Centessa Pharmaceuticals PLC is 1.32 times less risky than RAPT Therapeutics. It trades about 0.32 of its potential returns per unit of risk. RAPT Therapeutics is currently generating about -0.13 per unit of risk. If you would invest  1,564  in Centessa Pharmaceuticals PLC on November 10, 2024 and sell it today you would earn a total of  339.00  from holding Centessa Pharmaceuticals PLC or generate 21.68% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Centessa Pharmaceuticals PLC  vs.  RAPT Therapeutics

 Performance 
       Timeline  
Centessa Pharmaceuticals 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Centessa Pharmaceuticals PLC are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Centessa Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.
RAPT Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days RAPT Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, RAPT Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Centessa Pharmaceuticals and RAPT Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Centessa Pharmaceuticals and RAPT Therapeutics

The main advantage of trading using opposite Centessa Pharmaceuticals and RAPT Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, RAPT Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RAPT Therapeutics will offset losses from the drop in RAPT Therapeutics' long position.
The idea behind Centessa Pharmaceuticals PLC and RAPT Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments